Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 7, Issue 4, Pages e2201-e2201
Publisher
Springer Nature
Online
2016-04-21
DOI
10.1038/cddis.2015.324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
- (2014) N M A White et al. BRITISH JOURNAL OF CANCER
- Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
- (2014) N. Martinez-Bosch et al. CANCER RESEARCH
- αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer
- (2014) Anna Sophie Berghoff et al. CLINICAL & EXPERIMENTAL METASTASIS
- Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
- (2014) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
- (2014) Yulong Shang et al. CURRENT CANCER DRUG TARGETS
- Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
- (2014) Jay S. Desgrosellier et al. DEVELOPMENTAL CELL
- Galectin-1 Upregulates CXCR4 to Promote Tumor Progression and Poor Outcome in Kidney Cancer
- (2014) C.-S. Huang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- RETRACTED ARTICLE: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma
- (2014) Baoyu Lv et al. MOLECULAR NEUROBIOLOGY
- Integrin β3 links therapy resistance and cancer stem cell properties
- (2014) Nagarajan Kannan et al. NATURE CELL BIOLOGY
- An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
- (2014) Laetitia Seguin et al. NATURE CELL BIOLOGY
- Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
- (2014) P Zhang et al. Cell Death & Disease
- An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression
- (2013) Pengfei Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Unraveling galectin-1 as a novel therapeutic target for cancer
- (2013) Lucile Astorgues-Xerri et al. CANCER TREATMENT REVIEWS
- Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway
- (2013) Ya-Ling Hsu et al. CARCINOGENESIS
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
- (2013) Virginia Hernandez–Gea et al. GASTROENTEROLOGY
- αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma
- (2013) Xiao-Yong Huang et al. HEPATOLOGY
- miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma
- (2013) Zhong-Hua Tao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The epigenetics of epithelial-mesenchymal plasticity in cancer
- (2013) Wai Leong Tam et al. NATURE MEDICINE
- MEK in cancer and cancer therapy
- (2013) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
- (2012) Limin Xia et al. HEPATOLOGY
- CD151 Amplifies Signaling by Integrin α6β1 to PI3K and Induces the Epithelial–Mesenchymal Transition in HCC Cells
- (2011) Ai–Wu Ke et al. GASTROENTEROLOGY
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- (2010) Zhiwei Wang et al. DRUG RESISTANCE UPDATES
- Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion
- (2010) Wei Ding et al. HEPATOLOGY
- The evasive promise of antiangiogenic therapy
- (2009) Jean-François Dufour JOURNAL OF HEPATOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search